271 related articles for article (PubMed ID: 8174136)
1. Coactivation of the MDR1 and MYCN genes in human neuroblastoma cells during the metastatic process in the nude mouse.
Ferrandis E; Da Silva J; Riou G; Bénard I
Cancer Res; 1994 Apr; 54(8):2256-61. PubMed ID: 8174136
[TBL] [Abstract][Full Text] [Related]
2. MYCN enhances P-gp/MDR1 gene expression in the human metastatic neuroblastoma IGR-N-91 model.
Blanc E; Goldschneider D; Ferrandis E; Barrois M; Le Roux G; Leonce S; Douc-Rasy S; Bénard J; Raguénez G
Am J Pathol; 2003 Jul; 163(1):321-31. PubMed ID: 12819037
[TBL] [Abstract][Full Text] [Related]
3. Cell lineage and differentiation state are primary determinants of MYCN gene expression and malignant potential in human neuroblastoma cells.
Spengler BA; Lazarova DL; Ross RA; Biedler JL
Oncol Res; 1997; 9(9):467-76. PubMed ID: 9495452
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of MDR1 gene expression in neuroblastoma: results of a multivariate analysis.
Bénard J; Bourhis J; de Vathaire F; Ferrandis E; Terrier-Lacombe MJ; Lemerle J; Riou G; Hartmann O
Prog Clin Biol Res; 1994; 385():111-6. PubMed ID: 7972202
[TBL] [Abstract][Full Text] [Related]
5. N-myc regulation of type I insulin-like growth factor receptor in a human neuroblastoma cell line.
Chambéry D; Mohseni-Zadeh S; de Gallé B; Babajko S
Cancer Res; 1999 Jun; 59(12):2898-902. PubMed ID: 10383152
[TBL] [Abstract][Full Text] [Related]
6. CD44H expression by human neuroblastoma cells: relation to MYCN amplification and lineage differentiation.
Gross N; Beretta C; Peruisseau G; Jackson D; Simmons D; Beck D
Cancer Res; 1994 Aug; 54(15):4238-42. PubMed ID: 7518353
[TBL] [Abstract][Full Text] [Related]
7. Augmented MYCN expression advances the malignant phenotype of human neuroblastoma cells: evidence for induction of autocrine growth factor activity.
Schweigerer L; Breit S; Wenzel A; Tsunamoto K; Ludwig R; Schwab M
Cancer Res; 1990 Jul; 50(14):4411-6. PubMed ID: 2364393
[TBL] [Abstract][Full Text] [Related]
8. S-cells from a highly N-myc-amplified neuroblastoma are tumorigenic in nude mice.
Sleight BJ; Soukup S; Ballard ET; Parysek LM
Anticancer Res; 1993; 13(6A):2031-6. PubMed ID: 8297111
[TBL] [Abstract][Full Text] [Related]
9. Transfected neu oncogene induces human prostate cancer metastasis.
Zhau HY; Zhou J; Symmans WF; Chen BQ; Chang SM; Sikes RA; Chung LW
Prostate; 1996 Feb; 28(2):73-83. PubMed ID: 8604395
[TBL] [Abstract][Full Text] [Related]
10. Expression of the multidrug resistance-associated protein (MRP) gene correlates with amplification and overexpression of the N-myc oncogene in childhood neuroblastoma.
Bordow SB; Haber M; Madafiglio J; Cheung B; Marshall GM; Norris MD
Cancer Res; 1994 Oct; 54(19):5036-40. PubMed ID: 7923112
[TBL] [Abstract][Full Text] [Related]
11. In vitro effects of MYCN sense and antisense expression in MYCN-amplified human neuroblastoma cells.
Kavallaris M; Gardaneh M; Cheung B; Camacho ML; Hocker JE; Norris MD; Haber M; Marshall GM
Anticancer Res; 1998; 18(3A):1793-7. PubMed ID: 9673406
[TBL] [Abstract][Full Text] [Related]
12. The DDX1 gene maps within 400 kbp 5' to MYCN and is frequently coamplified in human neuroblastoma.
Amler LC; Schürmann J; Schwab M
Genes Chromosomes Cancer; 1996 Feb; 15(2):134-7. PubMed ID: 8834178
[TBL] [Abstract][Full Text] [Related]
13. Prolonged N-myc protein half-life in a neuroblastoma cell line lacking N-myc amplification.
Cohn SL; Salwen H; Quasney MW; Ikegaki N; Cowan JM; Herst CV; Kennett RH; Rosen ST; DiGiuseppe JA; Brodeur GM
Oncogene; 1990 Dec; 5(12):1821-7. PubMed ID: 2284101
[TBL] [Abstract][Full Text] [Related]
14. Stromal cells and human malignant neuroblasts derived from bone marrow metastasis may share common karyotypic abnormalities: the case of the IGR-N-91 cell line.
Valent A; Venuat AM; Danglot G; Da Silva J; Duarte N; Bernheim A; Bénard J
Med Pediatr Oncol; 2001 Jan; 36(1):100-3. PubMed ID: 11464856
[TBL] [Abstract][Full Text] [Related]
15. [Oncogen N-myc expression and measurement of DNA ploidy in neuroblastoma: a double staining flow cytometric analysis].
Chassevent A; Bénard J
Bull Cancer; 1997 Mar; 84(3):29-34. PubMed ID: 9207866
[TBL] [Abstract][Full Text] [Related]
16. [Increased expression of the MYCN oncogene in human neuroblastoma cells and possible, new therapeutic approaches].
Schweigerer L; Fotsis T
Klin Padiatr; 1991; 203(4):319-22. PubMed ID: 1942938
[TBL] [Abstract][Full Text] [Related]
17. Expression of B-myb in neuroblastoma tumors is a poor prognostic factor independent from MYCN amplification.
Raschellà G; Cesi V; Amendola R; Negroni A; Tanno B; Altavista P; Tonini GP; De Bernardi B; Calabretta B
Cancer Res; 1999 Jul; 59(14):3365-8. PubMed ID: 10416595
[TBL] [Abstract][Full Text] [Related]
18. MYCN downregulates integrin alpha1 to promote invasion of human neuroblastoma cells.
Tanaka N; Fukuzawa M
Int J Oncol; 2008 Oct; 33(4):815-21. PubMed ID: 18813796
[TBL] [Abstract][Full Text] [Related]
19. Integrin expression in human neuroblastoma cells with or without N-myc amplification and in ectopic/orthotopic nude mouse tumors.
Flickinger KS; Judware R; Lechner R; Carter WG; Culp LA
Exp Cell Res; 1994 Jul; 213(1):156-63. PubMed ID: 8020586
[TBL] [Abstract][Full Text] [Related]
20. Establishment of a hepatocellular carcinoma cell line with unique metastatic characteristics through in vivo selection and screening for metastasis-related genes through cDNA microarray.
Li Y; Tang Y; Ye L; Liu B; Liu K; Chen J; Xue Q
J Cancer Res Clin Oncol; 2003 Jan; 129(1):43-51. PubMed ID: 12618900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
